Medtronic has up to this point a old raise of its MiniMed 600 series insulin pumps to incorporate all with a doubtlessly problematic optimistic retainer ring, now not supreme these that appear damaged.
The U.S. Meals and Drug Administration presented on Oct. 5 that Medtronic will now change any MiniMed 600 series pump that has a favorable retainer ring with an up to this point pump that functions a shadowy retainer ring at no further worth, no topic guarantee house.
In November 2019, Medtronic first told patients to peek their pumps for capability ruin to the ring, and to contact the corporate if it seemed as if it would be free, damaged, or missing. In February 2020, the FDA designated the raise as class 1, “essentially the most severe form of raise,” for which exercise of the gadgets “can also cause severe accidents or death.”
On this case, one capability risk is hyperglycemia. This will occur if the reservoir isn’t at all times smartly locked into space by the retainer ring, and insulin isn’t at all times infused into the physique. That, in turn, can lead to diabetic ketoacidosis. One other risk is hypoglycemia, which might perchance also consequence from over-starting up of insulin if the retainer ring breaks or detaches and the user inserts the reservoir abet into the pump with the infusion space soundless connected to the physique.
Whereas severe accidents and deaths were reported with the exercise of Minimed series 600 insulin pumps, “these unfavorable events can also now not were without delay associated to the damaged optimistic retainer rings which shall be the root for this raise,” in conserving with the FDA leer. Nonetheless, complaints enjoy reportedly been filed.
The contemporary change is now not a consequence of any contemporary points, Medtronic spokesperson Pamela Reese told this news group. “Medtronic will proactively change all MiniMed 600 series insulin pumps with the optimistic retainer ring glean with the same pump that has an up to this point shadowy retainer ring glean, which is designed to better stand up to ruin sustained by an unintended fall or bump on a laborious floor.”
She added, “As we analyze the facts that we repeatedly come by on the security and performance of our insulin pumps, we glance for that patients who are soundless the utilization of the optimistic retainer ring can also doubtlessly bump into future complications. Resulting from this truth, we are for the time being accelerating our replacement as inventory permits over the coming months to place away with any capability performance concerns and optimize patient security and expertise.”
The company has replaced as regards to half of of the optimistic retainer ring pumps that were in exercise since November 2019, she mentioned.
The explicit insulin pump products are the mannequin 630G, dispensed between September 2016 and February 2020; and the 670G, dispensed between Would possibly perchance perchance perchance well 2015 and December 2020. The 630G is popular for americans customary 16 years and older, and the 670G — which works with a continuous glucose video display in a “hybrid closed-loop system — is readily within the market for americans with form 1 diabetes as young as 7 years of age.
This memoir within the muse seemed on MDedge.com, portion of the Medscape Legit Network.